Product

Company

Clareo Health | Investigating the Inotropic Potential of Apelin

NCT01179061·3 sites·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Edinburgh

Age

18–any

Sex

ALL

Healthy volunteers

Accepted

Healthy volunteers:
\>18yrs
Heart failure patients;
New York Heart Failure class II-IV
Ejection fractional \<35% or fractional shortening \<20% within previous 6months.

The record

StatusCompleted

PhaseNo phase

Taking part24

StartedAug 2010

UpdatedMay 9, 2024

Conditions

Where3

Clincial Research Facility, Royal Infirmary of Edinburgh, 51 Little France Cresc
Edinburgh, United Kingdom
Gareth Barnes
Edinburgh, United Kingdom
University of Edinburgh
Edinburgh, United Kingdom